Initiatives that used interdisciplinary teams, mostly comprised of nurses and pharmacists, often led to improvements in GDMT. Additional RCTs are necessary to better understand the efficacy and sustainability of other types of interventions. ja.ma/3UcOMdO

Proud to present our work at #HeartFailure2024 at Lisbon. HFimpEF pts may behave similar to HFrEF patients during a HF hospitalization. Thanks to my mentors Muthu Vaduganathan orlyvardeny scottdavidsolomon

📣 More ways to highlight your #HeartFunction science at HFSA #HFSA2024 👩🏽‍🔬 Late Breaking Clinical Research (not just trials!) 🏆 Case competition back for a 2nd year hfsa.org/asm/submit-you… Mitchell Psotka Dr Amanda Vest Laura Peters, DNP, FNP-C Aaron Bagnola James Fang Michael Felker

In EMPACT-MI, MI complicated by LV dysfxn or congestion portended a worse prognosis Regardless of LV dysfxn severity or presence/absence of congestion, #empagliflozin reduced both first & total HF hospitalizations but not mortality in the EMPACT-MI trial bit.ly/3x3G6hf

🚨 All-Generic Quadruple Therapy for HF on the Horizon 🚨 This week, U.S. FDA approved first generics of #ARNI sacubitril/valsartan. Joins first approved generics of #SGLT2i in ‘22. Still short while before these generics can be marketed One step closer… fda.gov/news-events/pr…

The KCMO score: intuitive (% of ideal 💊), patient-centric, can adapt as guidelines ∆, ↑ granularity vs existing methods. The new way to ⚖️ GDMT." Mirza Khan Saint Luke's Mid America Heart Institute @GCFMD Nobuhiro Ikemura @javedbutler1 Charles F. Sherrod IV, MD MSc #AHAJournals ahajrnls.org/3VC3yLQ

Empagliflozin Improves Diastolic Function in HFpEF by Restabilizing the Mitochondrial Respiratory Chain #AHAJournals ahajrnls.org/45rzp57

Equity in the Setting of Heart Failure Diagnosis: An Analysis of Differences Between and Within Clinician Practices Rebecca Tisdale MD, MPA Alex Sandhu #AHAJournals ahajrnls.org/3VmPVih

Hey pharmacists! Do you take care of patients with heart failure? Now is a great time to join HFSA ... We have a new pharmacist committee! Also membership is free if you are a student or trainee: hfsa.org/membership/mem… U-M Pharmacy ACCP Cardiology PRN AACP

Does the effect of flu vaccine vary dependent on immune response? Study examined the antibody response to high- vs. standard dose flu vaccine and its associations with clinical outcomes. ja.ma/4edLIX3 Alexander Peikert scottdavidsolomon orlyvardeny

Who receives the intervention among clinical trial enrollees after approval of a drug or device? Significant variation regionally! jacc.org/doi/10.1016/j.… JACC Journals #JACCHF

*Breaking* P3 #FINEARTSHF meets its primary endpoint (CVd+total HF events)! Non-steroidal MRA finerenone "demonstrates definitive CV benefits" in HFmrEF & HFpEF Looking forward to presenting full results at #ESCCongress alongside scottdavidsolomon Pardeep S Jhund bayer.com/media/en-us/fi…

I look forward to presenting the final results of FINEARTS-HF at the ESC Sept 1 in London bayer.com/media/en-us/fi…

It is fitting to have this primer on upfront combination therapy in HFpEF from Steve Greene and Robert Mentz, MD out in #HREV (link.springer.com/article/10.100…) ahead of FINEARTS presentation at ESC. Growing therapeutic options! Muthu Vaduganathan Andrew J Sauer MD Mikhail Kosiborod

Friday morning session at #ESC2024 Everything you wanted to learn about semaglutide, focused on obesity and heart failure, 😞 inflammation, atrial fibrillation, echo markers, CKD and more! 🔥 we kick off the Congress! European Society of Cardiology Mikhail Kosiborod Muthu Vaduganathan BiykemBozkurt

In patients with heart failure and mildly reduced or preserved ejection fraction, finerenone resulted in a lower rate of total worsening heart failure events and death from cardiovascular causes than placebo. Full FINEARTS-HF trial results: nej.md/470x4ix #ESCardio

FINEARTS - HF: a win for patients with HFmrEF/HFpEF. Multi-pillar approach to treating HF>40% now clearly emerging. Earlier implementation approaches now needed to fully realize the population level benefits.

Why Has it Been Challenging to Modify CKD Progression in Heart Failure? Our #simpub special communication in JACC Journals: - Slower rate of progression - Acute effects on GFR - Shorter follow-up - Competing/intercurrent events #ESCCongress sciencedirect.com/science/articl…

Tour de force of MRAs in HF across the EF spectrum to coincide with FINEARTS-HF. Led by Andrew J Sauer MD!

Yet another simultaneous publication from CTCPR Trials & CIRL during #ESC2024. The brilliant Dr Modin presenting: Excess mortality and hospitalizations associated with seasonal influenza in patients with heart failure Simultaneously published in JACC Journals 👇 jacc.org/doi/10.1016/j.…